Evidence map›Paper›PMID 25031461›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120.

Ricky Maung, Melanie M Hoefer, Ana B Sanchez, Natalia E Sejbuk, Kathryn E Medders, Maya K Desai, Irene C Catalan, Cari C Dowling, Cyrus M de Rozieres, Gwenn A Garden and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  6. Article
  7. Article
  8. The contributing role of CCR5 in dementia.Frontiers in neurology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Ricky MaungInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Melanie M HoeferInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Ana B SanchezInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Natalia E SejbukInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Kathryn E MeddersInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; Neuroscience, Aging and Stem Cell Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Maya K DesaiNeuroscience, Aging and Stem Cell Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Irene C CatalanInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Cari C DowlingInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Cyrus M de RozieresInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037;
Gwenn A GardenDepartment of Neurology, University of Washington, Seattle, WA 98195;
Rossella RussoNeuroscience, Aging and Stem Cell Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; Department of Pharmacobiology, University of Calabria, 87036 Arcavacata di Rende, Italy;
Amanda J RobertsMolecular and Cellular Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037;
Roy WilliamsBioinformatics Shared Resource, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; and.
Marcus KaulInfectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; Neuroscience, Aging and Stem Cell Research Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037; Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093 mkaul@sanfordburnham.org.
Sanford Burnham Prebys Medical Discovery Institute · USScripps Research Institute · USUniversity of Calabria · ITUniversity of Washington · US

Funding

Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
Interdisciplinary Research Fellowship in NeuroAIDSR25MH081482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIANA CHERNER · 2007 to 2026
$5.2M
Neuroprotection by IFN-beta in AIDSR01MH087332 · NIMH · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI KAUL, MARCUS · 2010 to 2019
$5.2M
Chemokine Receptor Signaling in HIV NeuropathologyR01NS050621 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUL, MARCUS · 2004 to 2007
$1.4M
Combined effect of Methamphetamine, HIV and HAART on neurons and macrophagesR03DA029480 · NIDA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUL, MARCUS · 2010 to 2011
$376k
NIDA NIH HHS DA02630NIDA NIH HHS DA029480NIDA NIH HHS P50 DA026306NIDA NIH HHS R03 DA029480NIMH NIH HHS MH081482NIMH NIH HHS MH087332NIMH NIH HHS R01 MH087332NIMH NIH HHS R25 MH081482NINDS NIH HHS NS050621NINDS NIH HHS R01 NS050621
6 · The paper itself

Abstract

The innate immune system has been implicated in several neurodegenerative diseases, including HIV-1-associated dementia. In this study, we show that genetic ablation of CCR5 prevents microglial activation and neuronal damage in a transgenic model of HIV-associated brain injury induced by a CXCR4-using viral envelope gp120. The CCR5 knockout (KO) also rescues spatial learning and memory in gp120-transgenic mice. However, the CCR5KO does not abrogate astrocytosis, indicating it can occur independently from neuronal injury and behavioral impairment. To characterize further the neuroprotective effect of CCR5 deficiency we performed a genome-wide gene expression analysis of brains from HIVgp120tg mice expressing or lacking CCR5 and nontransgenic controls. A comparison with a human brain microarray study reveals that brains of HIVgp120tg mice and HIV patients with neurocognitive impairment share numerous differentially regulated genes. Furthermore, brains of CCR5 wild-type and CCR5KO gp120tg mice express markers of an innate immune response. One of the most significantly upregulated factors is the acute phase protein lipocalin-2 (LCN2). Using cerebrocortical cell cultures, we find that LCN2 is neurotoxic in a CCR5-dependent fashion, whereas inhibition of CCR5 alone is not sufficient to abrogate neurotoxicity of a CXCR4-using gp120. However, the combination of pharmacologic CCR5 blockade and LCN2 protects neurons from toxicity of a CXCR4-using gp120, thus recapitulating the finding in CCR5-deficient gp120tg mouse brain. Our study provides evidence for an indirect pathologic role of CCR5 and a novel protective effect of LCN2 in combination with inhibition of CCR5 in HIV-associated brain injury.

Indexed as

HIV-1Acute-Phase ProteinsAIDS Dementia ComplexAnimalsCCR5 Receptor AntagonistsCells, CulturedDisease Models, AnimalGene Expression ProfilingGliosisHIV Envelope Protein gp120Lipocalin-2LipocalinsMaze LearningMemoryMiceMice, KnockoutAcute-Phase ProteinsCCR5 Receptor AntagonistsCXCR4 protein, mousegp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Lcn2 protein, mouseLipocalin-2LipocalinsOncogene ProteinsReceptors, CCR5Receptors, CXCR4

Identifiers

PMID25031461
PMCPMC4370188
OpenAlexW2149410369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.